Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.

Hepatitis Awareness Month --- May 2011

This month marks the 16th anniversary of Hepatitis Awareness Month in the United States. Viral hepatitis, particularly infection with hepatitis B virus (HBV) or hepatitis C virus (HCV), is a major cause of morbidity and mortality. This issue of MMWR includes a report that focuses on a recent trend in HCV infection.

The report shows an increase in cases of HCV infection during 2002--2009 among adolescents and young adults aged 15--24 years in Massachusetts and highlights the fundamental role of surveillance in identifying emerging patterns of transmission and developing appropriate public health response. The Massachusetts cases were reported from all areas of the state, primarily among non-Hispanic whites. Injection drug use (IDU) was the most common risk factor for HCV transmission, and the increase in case reports suggests an epidemic of HCV infection related to IDU in this age group in Massachusetts.

In 2010, the Institute of Medicine (IOM) of the National Academies of Sciences issued a report on viral hepatitis outlining recommendations for the prevention and control of HBV and HCV infection, including improvement in public health surveillance for viral hepatitis and viral hepatitis screening linked with prevention and care (1). In response to the IOM report, the U.S. Department of Health and Human Services is developing a comprehensive viral hepatitis action plan that will set forth strategies to improve viral hepatitis prevention, care, and treatment in the United States. Additional information regarding viral hepatitis is available from CDC at http://www.cdc.gov/hepatitis.

Reference

  1. Institute of Medicine. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. Washington, DC: National Academies Press; 2010. Available at http://www.nap.edu/openbook.php?record_id=12793&page=1. Accessed April 28, 2011.


Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.


All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #